Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone & Formoterol Administered Alone in Patients With Asthma

* Ages eligible for study: 12 years and above * Genders eligible for study: both * Prior steroid use: steroid-requiring or steroid-free Inclusion Criteria: * History of asthma for at least 12 months * For steriod-requiring patients, documented use of inhaled corticosteroid for at least 4 weeks prior to Screening Visit * For steroid-free patients, no history of inhaled steroid asthma medication for at least 12 weeks prior to Screening Visit * Demonstrate FEV-1 of 60-85% of predicted normal values at Screening and Baseline Visit * Documented reversibility of 15% within 12 months of Screening or at Screening Visit (15% increase from pre-FEV-1 levels following albuterol inhalation or nebulized albuterol administration) * Symptoms of asthma during Run-in * Females of childbearing potential must have a negative urine pregnancy test at Screening and Baseline Visits. Females are eligible only if they are not pregnant or lactating, and are either sterile, or using acceptable methods of contraception. * Must otherwise be healthy * Provide written informed consent. Wishes of minors must be respected. Exclusion Criteria: Patients will not be eligible for the study if they meet any of the following criteria: * Life-threatening asthma within the past year or during the Run-In Period. * History of systemic corticosteroid medication within 3 months before the Screening Visit. * History of omalizumab use within past 6 months. * History of leukotriene receptor antagonist use, e.g., montelukast, within past week. * Current evidence or history of any clinically significant disease or abnormality including uncontrolled hypertension, uncontrolled coronary artery disease, congestive heart failure, myocardial infarction, or cardiac dysrhythmia. * Upper or lower respiratory infection within 4 weeks prior to Screening Visit or during Run-In Period. * Significant, non-reversible, pulmonary disease (e.g., chronic obstructive pulmonary disease \[COPD\], cystic fibrosis, bronchiectasis). * Known Human Immunodeficiency Virus (HIV)-positive status. * Smoking history equivalent to "10 pack years". * Current smoking history within 12 months prior to Screening Visit. * Current evidence or history of alcohol and/or substance abuse within 12 months prior to Screening Visit. * Patients who are confined in institution.